Voyager Therapeutics
Stock Forecast, Prediction & Price Target
Voyager Therapeutics (VYGR) stock Price Target by analysts
$18
Potential upside: 408.47%
Voyager Therapeutics price prediction
What is Voyager Therapeutics stock analysts` prediction?
Voyager Therapeutics stock forecast: Based on 1 Wall Street analysts` predicted price targets for Voyager Therapeutics in the last 3 months, the avarage price target is $18, with a high forecast of $NaN. The average price target represents a 408.47% change from the last price of $3.54.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Voyager Therapeutics stock Price Target by analysts
Full breakdown of analysts given Voyager Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Jay Olson Oppenheimer | 0% 0/1 | 11 months ago | $18 408.47% upside | $6.92 | StreetInsider | Previous targets (0) |
Jack Allen Robert W. Baird | 0% 0/1 | about 1 year ago | $18 408.47% upside | $6.04 | StreetInsider | Previous targets (0) |
Laura Chico Wedbush | 0% 0/1 | over 1 year ago | $8 125.98% upside | $8.48 | StreetInsider | Previous targets (0) |
Jim Birchenough Wells Fargo | 0% 0/1 | over 1 year ago | $14 295.48% upside | $9 | StreetInsider | Previous targets (0) |
Joon Lee Truist Financial | 0% 0/1 | over 2 years ago | $18 408.47% upside | $9.88 | Benzinga | Previous targets (0) |
Voyager Therapeutics Financial Estimates
Voyager Therapeutics Revenue Estimates
Voyager Therapeutics EBITDA Estimates
Voyager Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $37.41M N/A | $40.90M 9.33% | $250.00M 511.16% | Avg: $51.84M Low: $6.30M High: $100.34M avg. -79.26% | Avg: $54.25M Low: $22.78M High: $90.74M avg. 4.64% | Avg: $73.66M Low: $30.92M High: $123.19M avg. 35.76% | Avg: $111.27M Low: $46.72M High: $186.09M avg. 51.05% |
Net Income
% change YoY
| $-66.03M N/A | $-46.40M 29.71% | $132.33M 385.14% | Avg: $-97.42M Low: $-139.94M High: $2.67M avg. -173.62% | Avg: $-109.61M Low: $-100.28M High: $-37.43M avg. -12.51% | Avg: $-62.92M Low: $-117.93M High: $-15.47M avg. 42.59% | Avg: $-32.98M Low: $-61.81M High: $-8.10M avg. 47.58% |
EBITDA
% change YoY
| $-73.61M N/A | $-50.83M 30.94% | $126.45M 348.74% | Avg: $-18.73M Low: $-36.26M High: $-2.27M avg. -114.81% | Avg: $-19.60M Low: $-32.79M High: $-8.23M avg. -4.64% | Avg: $-26.62M Low: $-44.52M High: $-11.17M avg. -35.76% | Avg: $-40.21M Low: $-67.25M High: $-16.88M avg. -51.05% |
EPS
% change YoY
| -$1.75 N/A | -$1.21 30.85% | $3.08 354.54% | Avg: -$1.68 Low: -$3.14 High: $0.06 avg. -154.40% | Avg: -$1.49 Low: -$2.25 High: -$0.84 avg. 11.29% | Avg: -$1.41 Low: -$2.65 High: -$0.35 avg. 5.00% | Avg: -$0.74 Low: -$1.39 High: -$0.18 avg. 47.58% |
Operating Expenses
% change YoY
| $111.03M N/A | $91.74M -17.37% | $127.99M 39.51% | Avg: $25.39M Low: $3.08M High: $49.14M avg. -80.16% | Avg: $26.57M Low: $11.15M High: $44.43M avg. 4.64% | Avg: $36.07M Low: $15.14M High: $60.33M avg. 35.76% | Avg: $54.49M Low: $22.88M High: $91.13M avg. 51.05% |
FAQ
What is Voyager Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -23.98% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is -139.94M, average is -97.42M and high is 2.67M.
What is Voyager Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 3.05% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $6.30M, average is $51.84M and high is $100.34M.
What is Voyager Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -22.62% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is -$3.14, average is -$1.68 and high is $0.06.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Voyager Therapeutics stock. The most successful analyst is Jay Olson.